10-18 December 2020
During an inspection looking at part of the service
We carried out this announced focused review between 10 and 18 December 2020. The purpose of this review was to assess the providers compliance against the warning notice issued following our inspection of the service carried out between 30 July to 14 September 2020. The full report on this previous inspection can be found by selecting the ‘all reports’ link for DMC Healthcare Limited on our website at www.cqc.org.uk.
Due to the issues associated with the COVID-19 pandemic we undertook remote interviews and review of evidence that the provider submitted to us electronically.
At this review we found the service had made significant improvements with regard to the monitoring of certain patient groups prescribed a particular medicine to treat severe acne and was compliant with the warning notice issued we had issued following our last inspection.
Our key findings were:
- The new clinical governance structure which had just been implemented at the time of our last inspection was still in place, including the national and regional clinical lead roles, which were all part time roles. However, we found that the roles and responsibilities of the regional and national leads were not clearly defined or understood by all staff.
- The service had reviewed and updated their standard operating procedures (SOPs) with regard to prescribing and patient monitoring requirements for this particular medicine. The service was in the process of reviewing and introducing new systems and processes.
- We found that leaders had shared information about changes to policies and procedures with staff but there was no clear process for assurance that all staff including clinicians had read and understood the revised protocols.
- Leaders in the service were assuring themselves that the systems for prescribing and monitoring patients prescribed this medicine were operating correctly through audits.
- Review of this particular medicine was a standing agenda item on the two weekly clinical governance meeting agenda.
We are mindful of the impact of COVID-19 pandemic on our regulatory function. This meant we took account of the exceptional circumstances arising as a result of the COVID-19 pandemic when considering what enforcement action was necessary and proportionate to keep people safe as a result of this inspection. We will continue to discharge our regulatory enforcement functions required to keep people safe and to hold providers to account where it is necessary for us to do so.
Dr Rosie Benneyworth BM BS BMedSci MRCGP
Chief Inspector of Primary Medical Services and Integrated Care